Ambrosia Biosciences Announces $25MM Series A Financing, Including Strategic Investment by Merck

Ambrosia Biosciences announces a second closing of its Series A financing. This closing was led by Merck with additional participation from existing investors. This financing will further expand preclinical development operations in our facility in Boulder, CO. BOULDER, Colo., Dec. 10,…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks